Linsheng Zhuo

462 total citations
35 papers, 351 citations indexed

About

Linsheng Zhuo is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Linsheng Zhuo has authored 35 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Organic Chemistry and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Linsheng Zhuo's work include Cancer Mechanisms and Therapy (9 papers), Computational Drug Discovery Methods (7 papers) and Quinazolinone synthesis and applications (7 papers). Linsheng Zhuo is often cited by papers focused on Cancer Mechanisms and Therapy (9 papers), Computational Drug Discovery Methods (7 papers) and Quinazolinone synthesis and applications (7 papers). Linsheng Zhuo collaborates with scholars based in China, Montenegro and South Korea. Linsheng Zhuo's co-authors include Wei Huang, Mingshu Wang, Guang‐Fu Yang, Zhen Wang, Fengxu Wu, Ge‐Fei Hao, Neng-Fang She, Peng Xue, Weifan Jiang and Yi Gong and has published in prestigious journals such as Coordination Chemistry Reviews, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Linsheng Zhuo

33 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linsheng Zhuo China	12	171	163	53	46	46	35	351
Fabien Lecomte United Kingdom	8	169 1.0×	236 1.4×	15 0.3×	44 1.0×	34 0.7×	9	432
Hanumantharayappa Bharathkumar India	9	209 1.2×	150 0.9×	54 1.0×	121 2.6×	16 0.3×	14	374
Qingwei Zhang China	12	270 1.6×	81 0.5×	14 0.3×	65 1.4×	25 0.5×	53	454
Kshitij Thakkar United States	10	143 0.8×	188 1.2×	27 0.5×	33 0.7×	8 0.2×	11	458
Nancy-Ellen Haynes United States	6	410 2.4×	84 0.5×	19 0.4×	25 0.5×	41 0.9×	7	697
Catherine A. Luu United States	4	407 2.4×	148 0.9×	17 0.3×	44 1.0×	56 1.2×	5	471
Ola I. A. Salem Egypt	14	217 1.3×	418 2.6×	17 0.3×	76 1.7×	58 1.3×	26	586
Yongjun Li China	11	213 1.2×	121 0.7×	14 0.3×	80 1.7×	19 0.4×	26	404
B.R. Vijay Avin India	10	197 1.2×	208 1.3×	20 0.4×	79 1.7×	20 0.4×	13	416
Mahmoud M. Gamal El‐Din South Korea	13	198 1.2×	316 1.9×	58 1.1×	39 0.8×	63 1.4×	17	405

Countries citing papers authored by Linsheng Zhuo

Since Specialization

Citations

This map shows the geographic impact of Linsheng Zhuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linsheng Zhuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linsheng Zhuo more than expected).

Fields of papers citing papers by Linsheng Zhuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linsheng Zhuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linsheng Zhuo. The network helps show where Linsheng Zhuo may publish in the future.

Co-authorship network of co-authors of Linsheng Zhuo

This figure shows the co-authorship network connecting the top 25 collaborators of Linsheng Zhuo. A scholar is included among the top collaborators of Linsheng Zhuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linsheng Zhuo. Linsheng Zhuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yuting, et al.. (2024). Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke. European Journal of Medicinal Chemistry. 278. 116795–116795. 4 indexed citations

An, Zhigang, et al.. (2024). Discovery of 7-(1-methyl-1H-pyrazol-4-yl)-1,6-naphthyridine derivatives as potent inhibitors of rearranged during transfection (RET) and RET solvent-front mutants for overcoming selpercatinib resistance. European Journal of Medicinal Chemistry. 279. 116891–116891. 1 indexed citations

Zhang, Xi, Ying Peng, Zhigang An, et al.. (2024). Structure-activity relationship study of novel evodiamine amino acid conjugates with potent anti-colorectal cancer efficacy. European Journal of Medicinal Chemistry. 283. 117132–117132. 2 indexed citations

Zhang, Xi, Yan Peng, Junbo Wu, et al.. (2024). Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry. 279. 116807–116807. 5 indexed citations

Wang, Xiaodong, Honghua Zhang, Xiao Hu, et al.. (2024). Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future. Medicinal Research Reviews. 45(1). 164–213. 7 indexed citations

Peng, Yan, Ying Peng, Weidong Zhang, et al.. (2024). Novel N-phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy. Frontiers in Pharmacology. 15. 1452904–1452904. 1 indexed citations

Wang, Chengkun, Weifan Jiang, Peng Xue, et al.. (2024). Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer. European Journal of Medicinal Chemistry. 273. 116500–116500. 6 indexed citations

Wang, Shuzhi, Shan Duan, Linsheng Zhuo, et al.. (2023). Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease. ACS Omega. 8(31). 28910–28923. 5 indexed citations

Li, Shuang, Yanli He, Yan Peng, et al.. (2023). Development of o-aminobenzamide salt derivatives for improving water solubility and anti-undifferentiated gastric cancer. Frontiers in Pharmacology. 14. 1118397–1118397. 3 indexed citations

10.

Zhuo, Linsheng, Siyi Zhang, Mingshu Wang, et al.. (2023). Structure-activity relationship study of 1,6-naphthyridinone derivatives as selective type II AXL inhibitors with potent antitumor efficacy. European Journal of Medicinal Chemistry. 265. 116090–116090. 3 indexed citations

11.

Zhang, Honghua, et al.. (2022). Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. European Journal of Medicinal Chemistry. 242. 114695–114695. 20 indexed citations

12.

Shi, Tao, Honghua Zhang, Linsheng Zhuo, et al.. (2022). Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor. Frontiers in Pharmacology. 13. 1043397–1043397. 2 indexed citations

13.

Mei, Long‐Can, et al.. (2022). Conformational adjustment overcomes multiple drug-resistance mutants of tropomyosin receptor kinase. European Journal of Medicinal Chemistry. 237. 114406–114406. 4 indexed citations

14.

Wang, Zhen, Ying Peng, Xi Zhang, et al.. (2022). Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship. European Journal of Medicinal Chemistry. 247. 115031–115031. 36 indexed citations

15.

Wang, Mingshu, Yi Gong, Zhi‐Cheng Yu, et al.. (2020). Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. Molecules. 25(23). 5667–5667. 1 indexed citations

16.

Chen, Tao, Linsheng Zhuo, Pengfei Liu, et al.. (2020). Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. European Journal of Medicinal Chemistry. 192. 112174–112174. 20 indexed citations

17.

Wu, Fengxu, Linsheng Zhuo, Fan Wang, et al.. (2020). Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead. iScience. 23(6). 101179–101179. 26 indexed citations

18.

Wang, Mingshu, et al.. (2019). Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. European Journal of Medicinal Chemistry. 185. 111803–111803. 25 indexed citations

19.

Zhuo, Linsheng, Mingshu Wang, Zhi‐Hui Ming, et al.. (2019). 2,7-naphthyridinone-based MET kinase inhibitors: A promising novel scaffold for antitumor drug development. European Journal of Medicinal Chemistry. 178. 705–714. 23 indexed citations

20.

She, Neng-Fang, Linsheng Zhuo, Wen Jiang, et al.. (2014). Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(15). 3351–3355. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact